Corcept Therapeutics Inc (CORT)
57.08
-1.24
(-2.13%)
USD |
NASDAQ |
Mar 26, 14:46
Corcept Therapeutics Price to Book Value: 8.861 for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 4.189 |
| Nektar Therapeutics | 2.457 |
| Supernus Pharmaceuticals Inc | 1.736 |
| Bristol-Myers Squibb Co | 7.345 |
| ACADIA Pharmaceuticals Inc | 3.862 |
Price to Book Value Related Metrics
| PE Ratio | 46.03 |
| PS Ratio | 9.599 |
| PEG Ratio | 1.508 |
| Price to Free Cash Flow | 33.08 |
| Price | 57.08 |
| Earnings Yield | 2.17% |
| Market Cap | 6.022B |
| PEGY Ratio | 1.508 |
| Operating PE Ratio | 47.31 |
| Normalized PE Ratio | 46.03 |